These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2881779)

  • 1. [Thyrotropin-binding inhibitory immunoglobulins G in thyroid gland cells in patients with Graves-Basedow disease. II. Various methodologic aspects of their analysis].
    Faryna M
    Endokrynol Pol; 1986; 37(4):153-61. PubMed ID: 2881779
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thyrotropin-binding inhibitory immunoglobulins G in thyroid gland cells in patients with Graves-Basedow disease. Clinical studies].
    Nauman J; Faryna M; Kwiatkowska-Dutkiewicz E; Roszkowska K
    Endokrynol Pol; 1986; 37(4):143-52. PubMed ID: 2881778
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship of thyroid antibodies to the postpartum recurrence of hyperthyroidism in Graves' disease.
    Chang TC; Chen FW; Tsai WY; Chen SH; Chang CC; Yu TK; Chen YP; Liaw KY
    Taiwan Yi Xue Hui Za Zhi; 1987 Feb; 86(2):171-7. PubMed ID: 2883249
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyroid-stimulating hormone receptor antibodies--the calm after the storm after the calm?
    Davies TF
    Mayo Clin Proc; 1988 Jul; 63(7):736-9. PubMed ID: 2898573
    [No Abstract]   [Full Text] [Related]  

  • 5. Preparation of 125I-labeled receptor-purified Graves' immunoglobulins: properties of their binding to human thyroid membranes.
    Endo K; Borges M; Amir S; Ingbar SH
    J Clin Endocrinol Metab; 1982 Sep; 55(3):566-76. PubMed ID: 6284786
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid stimulating immunoglobulins. The Watson Smith lecture 1983.
    Munro DS
    J R Coll Physicians Lond; 1984 Jul; 18(3):155-60. PubMed ID: 6147408
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoimmunity of thyroid disease. With emphasis on Graves' disease.
    van Ouwerkerk BM; Krenning EP; Docter R; Benner R; Hennemann G
    Neth J Med; 1985; 28(1):32-9. PubMed ID: 2858065
    [No Abstract]   [Full Text] [Related]  

  • 9. Assays of thyroid-stimulating antibody.
    McKenzie JM; Zakarija M
    Methods Enzymol; 1985; 109():677-91. PubMed ID: 2859517
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical relevance of immunological markers in Graves' disease.
    Mann K; Saller B; Hörmann R
    Exp Clin Endocrinol; 1991 May; 97(2-3):224-30. PubMed ID: 1680726
    [No Abstract]   [Full Text] [Related]  

  • 11. Thyroid stimulating immunoglobulins: measurement and clinical use.
    Ollis CA; Tomlinson S; Munro DS
    Clin Sci (Lond); 1985 Aug; 69(2):113-21. PubMed ID: 2866060
    [No Abstract]   [Full Text] [Related]  

  • 12. A new method for assessing the thyrotropin binding inhibitory activity in the immunoglobulins and whole serum of patients with Graves' disease.
    Borges M; Ingbar JC; Endo K; Amir S; Uchimura H; Nagataki S; Ingbar SH
    J Clin Endocrinol Metab; 1982 Mar; 54(3):552-8. PubMed ID: 6120179
    [No Abstract]   [Full Text] [Related]  

  • 13. TSH receptor antibody in autoimmune thyroiditis and its clinical significance.
    Chang TC; Chen FW; Chang CC; Liaw KY
    Taiwan Yi Xue Hui Za Zhi; 1986 Aug; 85(8):748-54. PubMed ID: 2878965
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation between thyroid adenylate cyclase-stimulating and thyrotropin-binding inhibitor immunoglobulins in Graves' disease.
    Chang TC; Chen FW; Chang CC; Liaw KY
    Taiwan Yi Xue Hui Za Zhi; 1985 May; 84(5):579-85. PubMed ID: 2864384
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical applications of measuring thyroid receptor antibodies, thyroid-stimulating and thyroid stimulation-blocking antibodies.
    Sasaki N; Tamaru K; Tsuyusaki T; Inomata H; Niimi H; Nakajima H
    Acta Paediatr Jpn; 1988; 30 Suppl():133-8. PubMed ID: 2906202
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins.
    Bech K
    Acta Endocrinol Suppl (Copenh); 1983; 254():3-38. PubMed ID: 6191508
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoantibodies to the TSH receptor.
    Zakarija M; McKenzie JM
    Exp Clin Endocrinol; 1991 May; 97(2-3):165-9. PubMed ID: 1680725
    [No Abstract]   [Full Text] [Related]  

  • 18. Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection.
    Yokoyama N; Izumi M; Katamine S; Nagataki S
    J Clin Endocrinol Metab; 1987 Feb; 64(2):215-8. PubMed ID: 2878934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On standardization of the radioreceptor assay for anti-thyrotropin receptor antibody.
    Tamaki H; Amino N; Miyai K
    Clin Chem; 1988 Aug; 34(8):1662. PubMed ID: 2900087
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
    Molnár I; Balázs C
    Acta Med Hung; 1991; 48(1-2):13-21. PubMed ID: 1813853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.